SequelSEC

Omada Health, Inc. OMDA

Services-Health Services · CIK 0001611115 · Fiscal year ends 1231

Revenue
$309.76M
Fiscal year ended 2026-06-30
Operating income
-$464.00K
Fiscal year ended 2026-06-30
Free cash flow
$22.72M
Fiscal year ended 2026-06-30

Omada Health, Inc. (OMDA) reported revenue of $309.76M and net income of $4.30M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Omada Health, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Health Services.

Income

Omada Health, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$309.76M
Cost of revenue$98.55M
Gross profit$211.21M
Operating income-$464.00K
Net income$4.30M
Research & development$49.18M
Weighted-average diluted sharesUnavailable
Pretax income$4.30M
Income tax expense$0
Diluted EPSUnavailable
Selling, general & administrative$162.50M
General & administrative$58.27M
Selling & marketing$104.23M

Balance

Omada Health, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$221.71M
Total assets$328.22M
Current assets$294.91M
Total liabilities$75.48M
Current liabilities$75.48M
Total equity incl. NCI$252.74M
Temporary (mezzanine) equity$0
Inventory$4.12M
Accounts receivable$56.57M
Goodwill$13.24M
Long-term debtUnavailable
Accounts payable$11.80M

Cash flow

Omada Health, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$23.68M
Capital expenditures$960.00K
Investing cash flow-$6.55M
Financing cash flow-$18.56M
Net change in cash-$1.43M
Stock-based compensation$17.12M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$5.90M

Derived

Omada Health, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$22.72M
Gross margin68.2%
Operating margin-0.1%
FCF margin7.3%
SBC / revenue5.5%
Current ratio3.91x
Revenue YoY growth47.6%
Net margin1.4%
R&D / revenue15.9%
CapEx / revenue0.3%
Long-term debt / equityUnavailable
Effective tax rate0.0%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open OMDA in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-07View SEC filing
10-Q · Filed 2026-05-08View SEC filing
10-K · Filed 2026-03-06View SEC filing
10-Q · Filed 2025-11-07View SEC filing
10-Q · Filed 2025-08-08View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.